Navigation Links
Function of new cancer genes discovered

Dutch researcher Sebastian Nijman has discovered new genes which are involved in the development of cancer. The results of his research have led to a new treatment for patients with an inherited form of cancer, cylindromatosis.

Patients with the very rare genetic condition cylindromatosis develop a lot of benign tumours on the skin. These tumours mainly occur on the head where they can cause serious malformations.

People with this disease have a mutated form of the protein CYLD. Nijman and his colleagues used genetic screens to discover the molecular mechanism underlying cylindromatosis. Nijman's research revealed that the CYLD protein plays an important role in the NF-kappa B signalling route. This is a cellular communications system which becomes overactive if the CYLD protein is mutated. This results in increased cell growth and the occurrence of tumours.

An important implication of this research is that inhibition of the NF-kappa B route in cylindromatosis patients could be an adequate form of treatment. Aspirin is a well-known inhibitor of this route and a clinical study into the effectiveness of aspirin ointment in the treatment of cylindromatosis is currently being carried out at the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital.

Fanconi anaemia

The researcher also investigated another form of inherited cancer, Fanconi anaemia. People with this disease develop many highly malignant tumours at a young age, because the cell repair system is incapble of detaching two linked DNA strands.

FANCD2 is a protein responsible for the repair of this DNA damage. The protein is linked to a second protein, ubiquitin, when the cell detects that DNA damage has occurred. Nijman identified a third protein, USP1, which detaches the FANCD2 from the ubiquitin. USP1 therefore plays a role in the repair of DNA damage and possibly in the development of cancer.


'"/>

Source:Netherlands Organization for Scientific Research


Page: 1

Related biology news :

1. DNA Recombination and Repair—A New Twist to RecA Function
2. Software Tool for Converting Scientific Text into a Database of Functional Relationships
3. Research Reveals Functions Of Harmful Shellfish Pathogens
4. Viral DNA sequence a possible trigger for breast cancer
5. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
6. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
7. Columbia research lifts major hurdle to gene therapy for cancer
8. Combination therapy boosts effectiveness of telomere-directed cancer cell death
9. Mitochondrial DNA mutations play significant role in prostate cancer
10. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
11. BRCA1 causes ovarian cancer through indirect, biochemical route
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... ... October 09, 2018 , ... Exalto Bearings UK, ... industries, announces the appointment of Mike Cosgrove as Business Manager. , Cosgrove has over ... for the day to day running of the Derby UK facility. , “We are ...
(Date:10/11/2018)... FREDERICK, Md. (PRWEB) , ... October 11, 2018 ... ... strong economy is the vision behind the National Institute for Innovation in Manufacturing ... an array of projects designed to advance biopharmaceutical manufacturing and workforce development in ...
(Date:10/5/2018)... N.J. (PRWEB) , ... October 04, 2018 , ... EDETEK, ... be exhibiting at the CDISC U.S. Interchange in Bethesda, MD on October 8-12, 2018. ... in Foster City, CA on November 5-6, 2018. , CDISC Interchanges are global ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... ... October 04, 2018 , ... Power T ... Spine Technology Award from Orthopedics This Week during the 2018 National Association of ... Handle is a surgical instrument that delivers operating room efficiencies through increased speed ...
(Date:10/2/2018)... Switzerland (PRWEB) , ... October ... ... provider of advanced software solutions for biopharmaceutical R&D, today announced a new ... mini-bioreactor systems from Sartorius, a leading international pharmaceutical and laboratory equipment supplier. ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, ... the availability of the GlycoMark test, the only FDA-cleared blood test specific to ... PMLS will promote and offer the GlycoMark test to its network of physicians ...
(Date:9/27/2018)... ... September 26, 2018 , ... Nvision Biomedical Technologies ... Screw System today at the North American Spine Society (NASS) Annual Meeting, held ... focus Pedicle Screw System, which received clearance from the U.S. Food and Drug ...
Breaking Biology Technology: